Skip to main content
. 2007 Jun 26;56(11):1599–1605. doi: 10.1136/gut.2007.123596

Table 2 Endoscopic stenting in bile duct injury patients. Short term complications and duration of treatment.

Cystic duct leakage n = 67 (%) CBD leakage n = 26 (%) CBD stricture n = 110 (%)
Days between LC and referral, median (range) 10 (1–40) 15 (3–61) 75 (4–2899)
Maximum stents inserted during procedure, median (range) 1 (1–3) 1 (1–4) 2 (1–7)
Number of stent changes, median (range) 2 (0–4) 2 (1–5) 4 (0–12)
Number of patients with a stent related complication 11 (16.4) 1 (3.8) 36 (32.7)
 Stent migration 5 (7.5) 0 21 (19.1)
 Clogging 5 (7.5) 1 (3.8) 15 (13.6)
 Cholangitis 1 (1.5) 0 6 (5.5)
 Fausse route 0 0 4 (3.6)
 Pain 2 (3.0) 0 18 (16.4)
Total duration of stents in situ, months
Mean (SD) 1.7 (1.0) 2.8 (3.0) 11.5 (9.4)
Median, (range) 1.5 (0.4–7.8) 1.8 (0.7–11.2) 11 (1–69)

BDI, bile duct injury; CBD, common bile duct; LC, laparoscopic cholecystectomy.